Chapter III Neuroanatomical studies of the opioid receptor-like-1 receptor and its endogenous neuropeptide orphanin FQ (nociceptin)

Handbook of Chemical Neuroanatomy

Volumn 20, Issue , 2002, Pages 103-193

  Neal Jr , Charles R ^a   Akil, Huda ^a   Watson Jr , Stanley J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0344512028     PISSN: 09248196     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0924-8196(02)80005-7     Document Type: Article

References (243)

1. 2+ channel current in rat sensory neurons by G-protein-independent mechanisms. J Neurosci 17 (1997) 8721-8728
2. Ahmadi S., Kotalla C., Guhring H., Takeshima H., Pahl A., and Zeilhofer H.U. Modulation of synaptic transmission by nociceptin/orphanin FQ and nocistatin in the spinal cord dorsal horn of mutant mice lacking the nociceptin/orphanin FQ receptor. Mol Pharmacol 59 (2001) 612-618
3. Ahmadi S., Liebel J.T., and Zeilhofer H.U. The role of the ORL1 receptor in the modulation of spinal neurotransmission by nociceptin/orphanin, FQ and nocistatin. Eur J Pharmacol 412 (2001) 39-44
4. Aitkin L.M., Irving D.R.F., and Webster W.R. Central neural mechanisms of hearing. In: Smith I.D. (Ed). Handbook of Physiology (1984), American Physiological Society, New York, New York 675-737
5. Alheid G.F., de Olmos J.S., and Beltramino C.A. The amygdala and extended amygdala. In: Paxinos G. (Ed). The Rat Nervous System (1995), Academic Press, Sydney 495-578
6. Allen C.N., Jiang Z.G., Teshima K., Darland T., Ikeda M., Nelson C.S., Quigley D.I., Yoshioka T., Allen R.G., Rea M.A., and Grandy D.K. Orphanin-FQ/nociceptin (OFQ/N) modulates the activity of suprachiasmatic nucleus neurons. J Neurosci 19 (2000) 2152-2160
7. Altschuler S.M., Bao X., Bieger D., Hopkins D.A., and Miselis R.R. Viscerotopic representation of the upper alimentary tract in the rat: sensory ganglia and nuclei of the solitary tract and spinal trigeminal tracts. J Comp Neurol 283 (1989) 248-268
8. Amano T., Matsubayashi H., Tamura Y., and Takahashi T. Orphanin FQ-induced outward current in rat hippocampus. Brain Res 853 (2000) 269-274
9. Anton B., Fein J., To T., Li X., Silberstein L., and Evans C.J. Immunohistochemical localization of ORL-1 in the central nervous system of the rat. J Comp Neurol 368 (1996) 229-251
10. 14-orphanin FQ with the orphanin FQ receptor: kinetics and modulation by cations and guanine nucleotides. Mol Pharmacol 51 (1997) 816-824
11. Armstead W.M. Nociceptin/orphanin FQ dilates pial arteries by K(ATP) and K(ca) channel activation. Brain Res 835 (1999) 315-323
12. Armstead W.M. Relationship between orphanin FQ and cerebral hemodynamics after hypoxia-ischemia in piglets. Am J Physiol Heart Circ Physiol 278 (2000) H477-H483
13. Armstead W.M. Altered release of prostaglandins contributes to hypoxic/ischemic impairment of NOC/OFQ cerebrovasodilation. Brain Res 859 (2000) 104-112
14. Armstead W.M. NOC/OFQ contributes to hypoxic-ischemic impairment of N-methyl-d-aspartate-induced cerebral vasodilation. Brain Res 868 (2000) 48-55
15. Armstead W.M. Role of NOC/OFQ in impaired opioid-induced pial artery dilation following brain injury. Brain Res 869 (2000) 231-235
16. Armstead W.M. Age dependent endothelin contribution to NOC/OFQ induced impairment of NMDA cerebrovasodilation after brain injury. Peptides 22 (2001) 39-46
17. Armstead W.M. NOC/OFQ and NMDA contribute to piglet hypoxic ischemic hypotensive cerebrovasodilation impairment. Pediatr Res 51 (2002) 586-591
18. Arndt M.L., Wu D., Soong Y., and Szeto H.H. Nociceptin/orphanin FQ increases blood pressure and heart rate via sympathetic activation in sheep. Peptides 20 (1999) 465-470
19. Borgland S.L., Connor M., and Christie M.J. Nociceptin inhibits calcium channel currents in a subpopulation of small nociceptive trigeminal ganglion neurons in mouse. J Physiol 536 (2001) 35-47
20. Borisova N.A., Proshlyakova E.V., Sapronova A.Y., and Ugrumov M.V. Androgen-dependent sex differences in the hypothalamic serotoninergic system. Eur J Endocrinol 134 (1996) 232-235
21. Bunzow J.R., Saez C., Mortrud M., Bouvier C., Williams J.T., Low M., and Grandy D.K. Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a mu, delta or kappa opioid receptor type. FEBS Lett 347 (1994) 284-288
22. Bucher B. ORL1-mediated inhibition by nociceptin of noradrenaline release from perivascular sympathetic nerve endings of the rat tail artery. Arch Pharmacol 358 (1998) 682-685
23. Butour J.L., Moisand C., Mazarguil H., Mollereau C., and Meunier J.C. Recognition and activation of the opioid receptor-like ORL 1 receptor by nociceptin, nociceptin analogs and opioids. Eur J Pharmacol 321 (1997) 97-103
24. Byrum C.E., and Guyenet P.G. Afferent and efferent connections of the A5 noradrenergic cell group in the rat. J Comp Neurol 261 (1987) 529-542
25. Ceccatelli S., Cortes R., and Hökfelt T. Effect of reserpine and colchicine on mRNA levels in the rat hypothalamic paraventricular nucleus. Brain Res Mol Brain Res 9 (1991) 57-69
26. Champion H.C., and Kadowitz P.J. Nociceptin, an endogenous ligand for the ORL1 receptor, has novel hypotensive activity in the rat. Life Sci 60 (1997) PL241-PL245
27. 1]-Nociceptin, a novel nociceptin analog, decreases systemic arterial pressure by a nalaxone-insensitive mechanism in the rat. Biochem Biophys Res Commun 234 (1997) 309-312
28. Champion H.C., Czapla M.A., and Kadowitz P.J. Nociceptin, an endogenous ligand for the ORL1 receptor, decreases cardiac output and total peripheral resistance in the rat. Peptides 18 (1997) 729-732
29. Champion H.C., Pierce R.L., and Kadowitz P.J. Nociceptin, a novel endogenous ligand for the ORL1 receptor, dilates isolated resistance arteries from the rat. Regul Pept 30 (1998) 69-74
30. Chen Y., Fan Y., Liu J., Mestek A., Tian M., Kozak C.A., and Yu L. Molecular cloning, tissue distribution and chromosomal localization of a novel member of the opioid receptor gene family. FEBS Lett 347 (1994) 279-283
31. Chen X., McClatchy D.B., Geller E.B., Liu-Chen L., Tallarida R.J., and Adler M.W. Possible mechanism of hypothermia induced by intracerebroventricular injection of orphanin FQ/nociceptin. Brain Res 904 (2001) 252-258
32. Chu X.N.X., Li P., Mao L., and Wang J.Q. Inhibition of cardiovascular activity following microinjection of novel opioid-like neuropeptide nociceptin (orphanin FQ) into the rat rostral ventrolateral medulla. Brain Res 829 (1999) 134-142
33. Ciccocioppo R., Angeletti S., Sanna P.P., Weiss F., and Massi M. Effect of nociceptin/orphanin FQ on the rewarding properties of morphine. Eur J Pharmacol 404 (2000) 153-159
34. Ciccocioppo R., Martin-Fardon P.P., Weiss F., and Massi M. Nociceptin/orphanin FQ inhibits stress- and CRF-induced anorexia in rats. NeuroReport 12 (2001) 1145-1149
35. Ciccocioppo R., Polidori C.L., Salvadori S., Guerrini R., and Massi M. Pharmacological characterization of the nociceptin receptor which mediates reduction of alcohol drinking in rats. Peptides 23 (2002) 117-125
36. Civelli O., Nothacker H.-P., Bourson A., Ardati A., Monsma F., and Reinscheid R. Orphan receptors and their natural ligands. J Recept Signal Transduct Res 17 (1997) 545-550
37. Connor M., and Christie M.J. Modulation of Ca2+ channel currents of acutely dissociated rat periaqueductal grey neurons. J Physiol 508 (1998) 47-58
38. Connor M., Vaughan C.W., Chieng B., and Christie M.J. Nociceptin receptor coupling to potassium conductance in locus coeruleus neurons in vitro. Br J Pharmacol 119 (1996) 1614-1618
39. Connor M., Vaughan C.W., Jennings E.A., Allen R.G., and Christie M.J. Nociceptin, Phe(1)psi-nociceptin(1-13), nocistatin and prepronociceptin(154-181) effects on calcium channel currents and a potassium current in rat locus coeruleus in vitro. Br J Pharmacol 128 (1999) 1779-1787
40. Cortes R., Ceccatelli S., Schalling M., and Hökfelt T. Differential effects of intracerebroventricular colchicine administration on the expression of mRNAs for neuropeptides and neurotransmitter enzymes, with special emphasis on galanin: an in situ hybridization study. Synapse 6 (1990) 369-391
41. Curro D., Yoo J.H., Anderson M., Song I., Del Valle J., and Owyang C. Molecular cloning of the orphanin FQ receptor gene and differential tissue expression of splice variants in rat. Gene 266 (2001) 139-145
42. Danielson P.B., and Dores R.M. Molecular evolution of the opioid/orphanin gene family. Gen Comp Endocrinol 113 (1999) 169-186
43. Danielson P.B., Hoversten M.T., Fitzpatrick M., Schreck C., Akil H., and Dores R.M. Sturgeon orphanin, a molecular "fossil" that bridges the gap between the opioids and orphanin FQ/nociceptin. J Biol Chem 276 (2001) 22114-22119
44. Davis E.C., Popper P., and Gorski R.A. The role of apoptosis in sexual differentiation of the sexually dimorphic nucleus of the preoptic area. Brain Res 734 (1996) 10-18
45. Dawson-Basoa M., and Gintzler A. Nociceptin (Orphanin FQ) abolishes gestational and ovarian sex steroid-induced antinociception and induces hyperalgesia. Brain Res 750 (1997) 48-52
46. Devine D.P., Taylor L., Reinscheid R.K., Monsma F.J., Civelli O., and Akil H. Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ. Neurochem Res 21 (1996) 1387-1396
47. Devine D.P., Reinscheid R.K., Monsma F.J., Civelli O., and Akil H. The novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion. Brain Res 727 (1996) 225-229
48. Devine D.P., Watson S.J., and Akil H. Nociceptin/orphanin FQ regulates neuroendocrine function of the limbic-hypothalamic-pituitary-adrenal axis. Neuroscience 102 (2001) 541-553
49. Dhandapani K.M., and Brann D.W. Orphanin FQ inhibits GnRH secretion from rat hypothalamic fragments but not GT1-7 neurons. NeuroReport 13 (2002) 1247-1249
50. Di Giannuario A., Pieretti S., Catalani A., and Loizzo A. Orphanin FQ reduces morphine-induced dopamine release in the nucleus accumbens: a microdialysis study in rats. Gen Comp Neurosci Lett 272 (1999) 183-186
51. Doi N., Dutia M.B., Brown C.H., Leng G., and Russell J.A. Inhibitory actions of nociceptin (orphanin FQ) on rat supraoptic nucleus oxytocin and vasopressin neurons in vitro. Adv Exp Med Biol 449 (1998) 147-151
52. Doi N., Dutia M.B., and Russell J.A. Inhibition of rat oxytocin and vasopressin supraoptic nucleus neurons by nociceptin in vitro. Neuroscience 84 (1998) 913-921
53. Dooley C.T., and Houghten R.A. Orphanin FQ: receptor binding and analog structure activity relationships in rat brain. Life Sci 59 (1996) PL23-PL29
54. Dooley C.T., Spaeth C.G., Berzetei-Gurske I.P., Craymer K., Adapa I.D., Brandt S.R., Houghten R.A., and Toll L. Binding and in vitro activities of peptides with high affinity for the nociceptin/orphanin FQ receptor, ORL1. J Pharm Exp Ther 283 (1997) 735-741
55. Evans C.J. Corrigendum. J Comp Neurol 412 (1999) 708
56. Faber E.S., Chambers J.P., Evans R.H., and Henderson G. Depression of glutamatergic transmission by nociceptin in the neonatal rat hemisected spinal cord preparation in vitro. Br J Pharmacol 119 (1996) 189-190
57. Florin S., Suaudeau C., Meunier J.C., and Costentin J. Nociceptin stimulates locomotion and exploratory behaviour in mice. Eur J Pharmacol 317 (1996) 9-13
58. Florin S., Suaudeau C., Meunier J.C., and Costentin J. Orphan neuropeptide NocII, a putative pronociceptin mutaration product stimulates locomotion in mice. NeuroReport 8 (1997) 705-707
59. 3H]nociceptin binding sites from telencephalon to mesencephalic regions in the mouse brain. Neurosci Lett 230 (1997) 33-36
60. Fukuda K., Kato S., Mori K., Nishi M., Takeshima H., Iwabe N., Miyata T., Houtani T., and Sugimoto T. cDNA cloning and regional distribution of a novel member of the opioid receptor family. FEBS Lett 343 (1994) 42-46
61. Gavioli E.C., Rae G.A., Calo G., Guerrini R., and De Lima T.C. Central injections of nocistatin or its C-terminal hexapeptide exert anxiogenic-like effect on behaviour of mice in the plus-maze test. Br J Pharmacol 136 (2002) 764-772
62. Gintzler A.R., Adapa I.D., Toll L., Medina V.M., and Wang L. Modulation of enkephalin release by nociceptin. Eur J Pharmacol 325 (1997) 29-34
63. Giuliani S., and Maggi C.A. Inhibition of tachykinin release from peripheral endings of sensory nerves by nociceptin, a novel opioid peptide. Br J Pharmacol 118 (1996) 1567-1569
64. Gorski R.A., Harlan R.E., Jacobson C.C., Shryne J.E., and Southam A.M. Evidence for the existence of a sexually dimorphic nucleus in the preoptic area of the rat. J Comp Neurol 193 (1980) 529-539
65. Griebel G., Perrault G., and Sanger D.J. Orphanin FQ, a novel neuropeptide with anti-stress-like activity. Brain Res 836 (1999) 221-224
66. Grisel J.E., Mogil J.S., Belknap J.K., and Grandy D.K. Orphanin FQ acts as a supraspinal, but not a spinal, anti-opioid peptide. NeuroReport 7 (1996) 2125-2129
67. Guerrini R., Calo G., Rizzi A., Bianchi C., Lazarus L.H., Salvadori S., Temussi P.A., and Regoli D. Address and message sequences for the nociceptin receptor: a structure-activity study of nociceptin-(1-13)-peptide amide. J Med Chem 40 (1997) 1789-1793
68. Guillamon A., Segovia S., and del Abril A. Early effects of gonadal steroids on the neuron number in the medial posterior region of the lateral division of the bed nucleus of the stria terminalis in the rat. Brain Res Dev Brain Res 44 (1988) 281-290
69. Gumusel B., Q H., Hyman A., Chang J.K., Kapusta D.R., and Lippton H. Nociceptin: an endogenous agonist for central opioid like1 (ORL1) receptors possesses systemic vasorelaxant properties. Life Sci 60 (1997) PL141-PL145
70. Gupta D.S., Kelson A.B., Polgar W.E., Toll L., Szucs M., and Gintzler A.R. Ovarian sex steroid-dependent plasticity of nociceptin/orphanin FQ and opioid modulation of spinal dynorphin release. J Pharmacol Exp Ther 298 (2001) 1213-1220
71. Halford W.P., Gebhardt B.M., and Carr D.J. Functional role and sequence analysis of a lymphocyte orphan opioid receptor. J Neuroimmunol 59 (1995) 91-101
72. Hao J.X., Wiesenfeld-Hallin Z., and Xu X.J. Lack of cross-tolerance between the antinoticeptive effect of intrathecal orphanin FQ and morphine in the rat. Neurosci Lett 223 (1997) 49-52
73. Hara N., Minami T., Okuda-Ashitaka E., Sugimoto T., Sakai M., Onaka M., Mori H., Imanishi T., Shingu K., and Ito S. Characterization of nociceptin hyperalgesia and allodynia in conscious mice. Br J Pharmacol 121 (1997) 401-408
74. Heinricher M.M., McGaraughty S., and Grandy D.K. Circuitry underlying antiopioid actions of orphanin FQ in the rostral ventromedial medulla. J Neurophysiol 78 (1997) 3351-3358
75. Henderson G., and McKnight A.T. The orphan opioid receptor and its endogenous ligand nociceptin/orphanin FQ. Trends Pharmacol Sci 18 (1997) 293-300
76. Herman J.P., and Cullinan W.E. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci 20 (1997) 78-84
77. Herman J.P., Chantal M.F., and Cullinan W.E. Neuronal circuit regulation of the hypothalamo-pituitary-adrenocortical stress axis. Crit Rev Neurobiol 10 (1996) 371-394
78. Higgins G.A., Kew J.N., Richards J.G., Takeshima H., Jenck F., Wichmann J., Kemp J.A., and Grottick A.J. A combined pharmacological and genetic approach to investigate the role of orphanin FQ in learning and memory. Eur J Neurosci 15 (2002) 911-922
79. Hiramatsu M., and Inoue K. Effects of nocistatin on nociceptin-induced impairment of learning and memory in mice. Eur J Pharmacol 367 (1999) 151-155
80. Houtani T., Nishi M., Takeshima H., Nukada T., and Sugimoto T. Structure and regional distribution of nociceptin/orphanin FQ precursor. Biochem Biophys Res Commun 219 (1996) 714-719
81. Houtani T., Nishi M., Takeshima H., Sato K., Sakuma S., Kakimoto S., Ueyama T., Noda T., and Sugimoto T. Distribution of nociceptin/orphanin FQ precursor protein and receptor in brain and spinal cord: a study using in situ hybridization and X-gal histochemistry in receptor-deficient mice. J Comp Neurol 424 (2000) 489-508
82. Hunter W.M., and Greenwood F.C. Preparation of iodine-131 labeled human growth hormone of high specific activity. Nature 194 (1962) 495-496
83. Ikeda K., Kobayashi K., Kobayashi T., Ichikawa T., Kumanishi T., Kishida H., Yano R., and Manabe T. Functional coupling of the nociceptin/orphanin FQ receptor with the G-protein-activated K+ (GIRK) channel. Brain Res Mol Brain Res 45 (1997) 117-126
84. Ikeda K., Watanabe M., Ichikawa T., Kobayashi T., Yano R., and Kumanishi T. Distribution of prepronociceptin/orphanin FQ mRNA and its receptor mRNA in developing and adult mouse central nervous system. J Comp Neurol 399 (1998) 139-151
85. Inoue M.I., Shimohira A., Yoshida A., Zimmer H., Takeshima T., Sakurada T., and Ueda H. Dose-related opposite modulation by nociceptin/orphanin FQ of substance P nociception in the nociceptors and spinal cord. J Pharmacol Exp Ther 291 (1999) 308-313
86. Jacobson C.D., and Gorski R.A. Neurogenesis of the sexually dimorphic nucleus of the preoptic area in the rat. J Comp Neurol 196 (1981) 519-529
87. Jagolino A., and Armstead W.M. Nociceptin/orphanin FQ contributes to hypoxic/ischemic impairment of hypercapnic cerebrovasodilation. Brain Res Bull 55 (2001) 465-468
88. Jakab R.L., and Leranth C. The septum. In: Paxinos G. (Ed). The Rat Nervous System (1995), Academic Press, Sydney 405-442
89. Jenck F., Moreau J.L., Martin J.R., Kilpatrick G.J., Reinscheid R.K., Monsma F.J., Nothacker H.-P., and Civelli O. Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. Proc Natl Acad Sci USA 94 (1997) 14854-14858
90. Jenck F., Wichmann J., Dautzenberg F., Moreau J.L., Ouagazzal A., Martin J.R., Lundstrom K., Cesura A., Poli S., Roever S., Kolczewski S., Adam G., and Kilpatrick G. A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat. Proc Natl Acad Sci USA 97 (2000) 4938-4943
91. + current induced by nociceptin in medullary dorsal horn neurons. NeuroReport 12 (2001) 645-648
92. Jhamandas K.H., Sutak M., and Henderson G. Antinociceptive and morphine modulatory actions of spinal orphanin FQ. Can J Physiol Pharmacol 76 (1998) 314-324
93. Kachaturian H., Lewis M.E., Schafer M.-H., and Watson S.J. Anatomy of the CNS opioid systems. Trends Neurosci 8 (1985) 111-119
94. Kakimoto S., Houtani T., Sato K., Ueyama T., Sakuma S., Munemoto Y., Ohishi H., Kase M., Yamashita T., Takeshima H., and Sugimoto T. Brainstem auditory regions in mice: expression of nociceptin/orphanin FQ precursor mRNA in select neurons. Neurosci Lett 314 (2001) 37-40
95. Kapusta D.R., and Kenigs V.A. Cardiovascular and renal responses produced by central orphanin FQ/nociceptin occur independent of renal nerves. Am J Physiol 277 (1999) R987-R995
96. Kapusta D.R., Sezen S.F., Chang J.K., Lippton H., and Kenigs V.A. Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ). Life Sci 60 (1997) PL15-PL21
97. Kapusta D.R., Dayan L.A., and Kenigs V.A. Nociceptin/Orphanin FQ modulates the cardiovascular, but not renal, responses to stress in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 29 (2002) 254-259
98. Kest B., Hopkins E., Palmese C.A., Chen Z.P., Mogil J.S., and Pintar J.E. Morphine tolerance and dependence in nociceptin/orphanin FQ transgenic knock-out mice. Neurosci 104 (2001) 217-222
99. King T.R., and Nance D.M. Neuroestrogenic control of feeding behavior and body weight in rats with kainic acid lesions of the lateral septal area. Physiol Behav 37 (1986) 475-481
100. King M.A., Rossi G.C., Chang A.H., Williams L., and Pasternak G.W. Spinal analgesic activity of orphanin FQ/nociceptin and its fragments. Neurosci Lett 223 (1997) 113-116
101. Kiyama H., and Emson P.C. Colchicine-induced expression of proneurotensin mRNA in rat striatum and hypothalamus. Brain Res Mol Brain Res 9 (1991) 353-358
102. Knoflach F., Reinscheid R.K., Civelli O., and Kemp J.A. Modulation of voltage-gated calcium channels by orphanin FQ in freshly dissociated hippocampal neurons. J Neurosci 16 (1996) 6657-6664
103. Kolesnikov Y.A., and Pasternak G.W. Peripheral orphanin FQ/nociceptin analgesia in the mouse. Life Sci 64 (1997) 2021-2028
104. Koob G.F., Swerdlow N.R., Vaccarino F., Hubner C., Pulvirenti L., and Weiss F. Functional output of the basal forebrain. In: Napier T.C., Kalivas P.W., and Hanin I. (Eds). The Basal Forebrain: Anatomy to Function (1991), Plenum Press, New York 291-305
105. Koster A., Montkowski A., Schulz S., Stube E., Knaudt K., Jenck F., Moreau J.L., Nothacker H.-P., Civelli O., and Reinscheid R.K. Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice. Proc Natl Acad Sci USA 96 (1999) 10444-10449
106. Kotlinska J., Suder P., Legowska A., Rolka K., and Silberring J. Orphanin FQ/nociceptin inhibits morphine withdrawal. Life Sci 66 (2000) PL119-PL123
107. Kotlinska J., Wichmann J., Legowska A., Rolka K., and Silberring J. Orphanin FQ/nociceptin but not Ro 65-6570 inhibits the expression of cocaine-induced conditioned place preference. Behav Pharmacol 13 (2002) 229-235
108. 3H]nociceptin binding in rat brain and spinal cord. Biol Pharm Bull 24 (2001) 902-905
109. Lachowicz J.E., Shen Y., Monsma F.J., and Sibley D.R. Molecular cloning of a novel G protein-coupled receptor related to the opiate receptor family. J Neurochem 64 (1994) 34-40
110. Lai C.C., Wu S.Y., Dun S.L., and Dun N.J. Nociceptin-like immunoreactivity in the dorsal horn and inhibition of substantia gelatinosa neurons. Neuroscience 81 (1997) 887-891
111. Laudenbach V., Calo G., Guerrini R., Lamboley G., Benoist J.F., Evrard P., and Gressens P. Nociceptin/orphanin FQ exacerbates excitotoxic white-matter lesions in the murine neonatal brain. J Clin Invest 107 (2001) 457-466
112. 10]orphanin FQ(1-11) binding sites in rat brain. J Comp Neurol 423 (2000) 319-329
113. Leventhal L., Mathis J.P., Rossi G.C., Pasternak G.W., and Bodnar R.J. Orphanin opioid receptor antisense probes block orphanin FQ-induced hyperphagia. Eur J Pharmacol 349 (1998) R1-R3
114. Liebel J.T., Swandulla D., and Zeilhofer H.U. Modulation of excitatory synaptic transmission by nociceptin in superficial dorsal horn neurons of the neonatal rat spinal cord. Br J Pharmacol 121 (1997) 425-432
115. 2+ pathway. Biochem Biophys Res Commun 240 (1997) 304-308
116. Lutfy K., Hossain S.M., Khaliq I., and Maidment N.T. Orphanin FQ/nociceptin attenuates development of morphine tolerance in rats. Br J Pharmacol 134 (2001) 529-534
117. Lutfy K., Do T., and Maidment N.T. Orphanin FQ/nociceptin attenuates motor stimulation and changes in nucleus accumbens extracellular dopamine induced by cocaine in rats. Psychopharmacology (Berl) 154 (2001) 1-7
118. Luo C., Kumamoto E., Furue H., and Yoshimura M. Nociceptin-induced outward current in substantia gelatinosa neurons of the adult rat spinal cord. Neurosci 108 (2001) 323-330
119. Ma L., Cheng Z.L., Fan G.H., Cai Y.C., Jiang L.Z., and Pei G. Functional expression, activation and desensitization of opioid receptor-like receptor ORL1 in neuroblastoma × glioma NG108-15 hybrid cells. FEBS Lett 403 (1997) 91-94
120. Madamba S.G., Schweitzer P., and Siggins G.R. Nociceptin augments K(+) currents in hippocampal CA1 neurons by both ORL-1 and opiate receptor mechanisms. J Neurophysiol 82 (1999) 1776-1785
121. Madeira M.D., Sousa N., and Paula-Barbosa M.M. Sexual dimorphism in the mossy fiber synapses of the rat hippocampus. Exp Brain Res 87 (1991) 537-545
122. Maidment N.T., Chen Y., Tan A.M., Murphy N.P., and Leslie F.M. Rat ventral midbrain dopamine neurons express the orphanin FQ/nociceptin receptor ORL-1. NeuroReport 13 (2002) 1137-1140
123. Makman M.H., Lyman W.D., and Dvorkin B. Presence and characterization of nociceptin (orphanin FQ) receptor binding in adult rat and human fetal hypothalamus. Brain Res 762 (1997) 247-250
124. Mamiya T., Noda M., Takeshima H., and Nabeshima T. Enhancement of spatial attention in nociceptin/orphanin FQ receptor-knockout mice. Brain Res 783 (1998) 236-240
125. Mamiya T., Noda Y., Ren X., Nagai T., Takeshima H., Ukai M., and Nabeshima T. Morphine tolerance and dependence in the nociceptin receptor knockout mice. J Neural Transm 108 (2001) 1349-1361
126. Manabe T., Noda Y., Mamiya T., Katagirl H., Houtani T., Nishi M., Noda T., Takahashi T., Sugimoto T., Nabeshima T., and Takeshima H. Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors. Nature 394 (1998) 577-581
127. Mansour A., Kachaturian H., Lewis M.E., Akil H., and Watson S.J. Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J Neurosci 7 (1987) 2445-2464
128. Mansour A., Thompson R.C., Akil H., and Watson S.J. Delta opioid receptor mRNA distribution in the brain: comparison to delta receptor binding and proenkephalin mRNA. J Chem Neuroanat 6 (1993) 351-362
129. Mansour A., Fox C.A., Burke S., Meng F., Thompson R.C., Akil H., and Watson S.J. Mu, delta and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J Comp Neurol 350 (1994) 412-438
130. Mansour A., Fox C.A., Burke S., Akil H., and Watson S.J. Immunohistochemical localization of the cloned μ opioid receptor in the rat CNS. J Chem Neuroanat 8 (1995) 283-305
131. Mansour A., Fox C.A., Akil H., and Watson S.J. Opioid receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci 18 (1995) 22-29
132. Mao L., and Wang J.Q. Microinjection of orphanin FQ into nucleus tractus solitarii elevates blood pressure and heart rate in both anesthetized and conscious rats. J Pharmacol Exp Ther 294 (2000) 255-262
133. Marchese A., Docherty J.M., Nguyen T., Heiber M., Cheng R., Heng H.H., Tsui L.C., Shi X., George S.R., and O'Dowd B.F. Cloning of human genes encoding novel G protein-coupled receptors. Genomics 23 (1994) 609-618
134. Martin-Fardon R., Ciccocioppo R., Massi M., and Weiss F. Nociceptin prevents stress-induced ethanol- but not cocaine-seeking behavior in rats. NeuroReport 11 (2000) 1939-1943
135. (in Russian). Maslov L.N., Krylatov A.V., Lishmanov I., and Albrecht E. The anti-arrhythmia properties of the functional opioid agonist orphanin FQ (nociceptin). Eksp Klin Farmakol 62 (1999) 21-24
136. Mathis J.P., Ryan-Moro J., Chang A., Hom J.S., Scheinberg D.A., and Pasternak G.W. Biochemical evidence for orphanin FQ/nociceptin receptor heterogeneity in mouse brain. Biochem Biophys Res Commun 230 (1997) 462-465
137. Mathis J.P., Goldberg I.E., Letchworth S.R., Ryan-Moro J., and Pasternak G.W. Identification of a high-affinity orphanin FQ/nociceptin(1-11) binding site in mouse brain. Synapse 34 (1999) 181-186
138. Mathis J.P., Rossi G.C., Pellegrino M.J., Jimenez C., Pasternak G.W., and Allen R.G. Carboxyl terminal peptides derived from prepro-orphanin FQ/nociceptin (ppOFQ/N) are produced in the hypothalamus and possess analgesic bioactivities. Brain Res 895 (2001) 89-94
139. Meis S., and Pape H.C. Control of glutamate and GABA release by nociceptin/orphanin FQ in the rat lateral amygdala. J Physiol 532 (2001) 701-712
140. Meng F., Taylor L.P., Hoversten M.T., Ueda Y., Ardati A., Reinscheid R.K., Monsma F.J., Watson S.J., Civelli O., and Akil H. Moving from the orphanin FQ receptor to an opioid receptor using four point mutations. J Biol Chem 271 (1996) 32016-32020
141. Menzies J.R., and Corbett A.D. Nociceptin inhibits tonic nitric oxide release in the mouse isolated proximal colon. Eur J Pharmacol 388 (2000) 183-186
142. Meunier J.C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., Butour J.L., Guillemot J.C., Ferrara P., Monsarrat B., Mazarguil H., Vassart G., Parmentier M., and Costentin J. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 377 (1995) 532-535
143. Minami T., Okuda-Ashitaka E., Nishizawa M., Mori H., and Ito S. Inhibition of nociceptin-induced allodynia in conscious mice by prostaglandin D2. Br J Pharmacol 122 (1997) 605-610
144. Mogil J.S., and Pasternak G.W. The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacol Rev 53 (2001) 381-415
145. Mogil J.S., Grisel J.E., Zhangs G., Belknap J.K., and Grandy D.K. Functional antagonism of mu-, delta- and kappa-opioid antinociception by orphanin FQ. Neurosci Lett 214 (1996) 131-134
146. Mogil J.S., Grisel J.E., Reinscheid R.K., Civelli O., Belknap J.K., and Grandy D.K. Orphanin FQ is a functional anti-opioid peptide. Neuroscience 75 (1996) 333-337
147. Mogil J.S., Nessim L.A., and Wilson S.G. Strain-dependent effects of supraspinal orphanin FQ on thermal nociceptive sensitivity in mice. Neurosci Lett 261 (1999) 147-150
148. Mollereau C., Parmentier M., Mailleux P., Butour J.L., Moisand C., Chalon P., Caput D., Vassart G., and Meunier J.C. ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett 341 (1994) 33-38
149. 280 by His in TM6 of the human ORL1 receptor increases affinity but reduces intrinsic activity of opioids. FEBS Lett 395 (1996) 17-21
150. Mollereau C., Simons M.J., Soularue P., Liners F., Vassart G., Meunier J.C., and Parmentier M. Structure, tissue distribution, and chromosomal localization of the prepronociceptin gene. Proc Natl Acad Sci USA 93 (1996) 8666-8670
151. Monteillet G., Fein J., Anton B., and Evans C. ORL-1 and mu opioid receptor antisera label different fibers in areas involved in pain processing. J Comp Neurol 399 (1998) 373-383
152. Morgan M.M., Grisel J.E., Robbins C.S., and Grandy D.K. Antinociception mediated by the periaqueductal gray is attenuated by orphanin FQ. NeuroReport 8 (1997) 3431-3434
153. Murphy N.P., and Maidment N.T. Orphanin FQ/nociceptin modulation of mesolimbic dopamine transmission determined by microdialysis. J Neurochem 73 (1999) 179-186
154. Murphy N.P., Ly H.T., and Maidment N.T. Intracerebroventricular orphanin FQ/nociceptin suppresses dopamine release in the nucleus accumbens of anaesthetized rats. Neuroscience 75 (1996) 1-4
155. Murphy N.P., Lee Y., and Maidment N.T. Orphanin FQ/nociceptin blocks acquisition of morphine place preference. Brain Res 832 (1999) 168-170
156. Nakano H., Minami T., Abe K., Arai T., Tokumura M., Ibii N., Okuda-Ashitaka E., Mori H., and Ito S. Effect of intrathecal nocistatin on the formalin-induced pain in mice versus that of nociceptin/orphanin FQ. J Pharmacol Exp Ther 292 (2000) 331-336
157. Narayanan S., and Maidment N.T. Orphanin FQ and behavioral sensitization to cocaine. Pharmacol Biochem Behav 63 (1999) 271-277
158. Narayanan S., Lutfy K., and Maidment N.T. Sensitization to cocaine after a single intra-cerebral injection of orphanin FQ/nociceptin. Behav Brain Res 131 (2002) 97-103
159. Neal C.R., and Newman S.W. Prodynorphin peptide distribution in the forebrain of the Syrian hamster and rat: a comparative study with antisera against dynorphin A, dynorphin B and the C-terminus of the prodynorphin precursor molecule. J Comp Neurol 288 (1989) 353-386
160. Neal C.R., Mansour A., Reinscheid R., Nothacker H.-P., Civelli O., and Watson S.J. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J Comp Neurol 406 (1999) 503-547
161. 14Tyr]-orphanin FQ binding with the ORL1 receptor. J Comp Neurol 412 (1999) 563-605
162. Neil J.J., and Loewy A.D. Decreases in blood pressure in response to l-glutamate microinjections into the A5 catacholamine cell group. Brain Res 241 (1982) 271-278
163. Nicol B., Lambert D.G., Rowbotham D.J., Smart D., and McKnight A.T. Nociceptin induced inhibition of K+evoked glutamate release from rat cortical slices. Br J Pharmacol 119 (1996) 1081-1083
164. Nicholson J.R., Peterson S.J., Menzies J.R.W., Corbett A.D., and McKnight A.T. Pharmacological studies on the 'orphan' opioid receptor in central and peripheral sites. Can J Physiol Pharmacol 76 (1998) 304-313
165. Nishi M., Houtani T., Noda Y., Sato K., Doi T., Kuno J., Takeshima H., Nukada T., Nabeshima T., Yamashita T., Noda T., and Sugimoto T. Unrestrained nociceptive response and dysregulation of hearing ability in mice lacking the nociceptin/orphanin FQ receptor. EMBO J 16 (1997) 1858-1864
166. Nishizuka M., and Arai Y. Male-female differences in the intra-amygdaloid input to the medial amygdala. Exp Brain Res 52 (1983) 328-332
167. Norton C.S., Neal C.R., Kumar S., Akil H., and Watson S.J. Nociceptin/orphanin FQ and opioid receptor-like receptor mRNA expression in dopamine systems. J Comp Neurol 444 4 (2002) 358-368
168. Nothacker H.-P., Reinscheid R.K., Mansour A., Henningsen R.A., Ardati A., Monsma F.J., Watson S.J., and Civelli O. Primary structure and tissue distribution of the orphanin FQ precursor. Proc Natl Acad Sci USA 93 (1996) 8677-8682
169. Okuda-Ashitaka E., and Ito S. Nocistatin: a novel neuropeptide encoded by the gene for the nociceptin/orphanin FQ precursor. Peptides 21 (2000) 1101-1109
170. Okuda-Ashitaka E., Minami T., Tachibana S., Yoshihar Y., Nishiuchi Y., Kimura T., and Ito S. Nocistatin, a peptide that blocks nociceptin action in pain transmission. Nature 392 (1998) 286-289
171. Olszewski P.K., Billington C.J., and Levine A.S. Fos expression in
172. Olszewski P.K., Grace M.K., Sanders J.B., Billington C.J., and Levine A.S. Effect of nociceptin/orphanin FQ on food intake in rats that differ in diet preference. Pharmacol Biochem Behav 73 (2002) 529-535
173. Osinski M.A., Pampusch M.S., Murtaugh M.P., and Brown D.R. Cloning, expression and functional role of a nociceptin/orphanin FQ receptor in the porcine gastrointestinal tract. Eur J Pharmacol 365 (1999) 281-289
174. Pan Y.X., Xu J., and Pasternak G.W. Cloning and expression of a cDNA encoding a mouse brain orphanin FQ/nociceptin precursor. Biochem J 315 (1996) 11-13
175. Pan Z., Hirakawa N., and Fields H.L. A cellular mechanism for the bi-directional pain-modulating actions of orphanin FQ/nociceptin. Neuron 26 (2000) 515-522
176. Pietras T.A., and Rowland N.E. Effect of opioid and cannabinoid receptor antagonism on OFQ-induced hyperphagia in rats. Eur J Pharmacol 442 (2002) 237-239
177. Plotsky P.M., Cunningham E.T., and Widmaier E.P. Catecholaminergic modulation of corticotrophin-releasing factor and adrenocorticotropin. Endocr Rev 10 (1989) 437-451
178. Pomonis J.D., Billington C.J., and Levine A.S. Orphanin FQ, agonist of orphan opioid receptor ORL1, stimulates feeding in rats. NeuroReport 8 (1996) 369-371
179. Przewlocki R., and Przewlocka B. Opioids in chronic pain. Eur J Pharmacol 429 (2001) 79-91
180. Pu L., Bao G.B., Ma L., and Pei G. Acute desensitization of nociceptin/orphanin FQ inhibition of voltage-gated calcium channels in freshly dissociated hippocampal neurons. Eur J Neurosci 11 (1999) 3610-3616
181. Quigley D.I., McDougall J., Darland T., Zhang G., Ronnekleiv O., Grandy D.K., and Allen R.G. Orphanin FQ is the major OFQ 1-17-containing peptide produced in the rodent and monkey hypothalamus. Peptides 19 (1998) 133-139
182. Rodrobe J.P., Calo G., Regoli D., and Quirion R. Nociceptin receptor antagonists display antidepressant-like properties in the mouse forced swimming test. Naunyn Schmiedebergs Arch Pharmacol 365 (2002) 164-167
183. Reinscheid R.K., Nothacker H.-P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma F.J., and Civelli O. Orphanin FQ: a neuropeptide that activates an opioid-like G protein-coupled receptor. Science 270 (1995) 792-794
184. Reinscheid R.K., Ardati A., Monsma F.J., and Civelli O. Structure-activity relationship studies on the novel neuropeptide orphanin FQ. J Biol Chem 271 (1996) 14163-14168
185. Reinscheid R.K., Higelin J., Henningsen R.A., Monsma F.J., and Civelli O. Structures that delineate orphanin FQ and dynorphin A pharmacologic selectivities. J Biol Chem 273 (1998) 1490-1495
186. Riedl M., Shuster S., Vulchanova L., Wang J., Loh H.H., and Elde R. Orphanin FQ/nociceptin-immunoreactive nerve fibers parallel those containing endogenous opioids in rat spinal cord. NeuroReport 7 (1996) 1369-1372
187. Rizzi A., Bigoni R., Marzola G., Guerrini R., Salvadori S., Regoli D., and Calo G. Characterization of the locomotor activity-inhibiting effect of nociceptin/orphanin FQ in mice. Naunyn Schmiedebergs Arch Pharmacol 363 (2001) 161-165
188. Rizzi A., Marzola G., Bigoni R., Guerrini R., Salvadori S., Mogil J.S., Regoli D., and Calo G. Endogenous nociceptin signaling and stress-induced analgesia. NeuroReport 12 (2001) 3009-3013
189. Rossi G.C., Leventhal L., and Pasternak G.W. Naloxone sensitive orphanin FQ-induced analgesia in mice. Eur J Pharmacol 311 (1996) R7-R8
190. Rossi G.C., Leventhal L., Bolan E., and Pasternak G.W. Pharmacological characterization of orphanin FQ/nociceptin and its fragments. J Pharmacol Exp Ther 282 (1997) 858-865
191. 141-157, in mice. NeuroReport 9 (1998) 1165-1168
192. Saito Y., Maruyama K., Saido T.C., and Kawashima S. N23K, a gene transiently up-regulated during neural differentiation, encodes a precursor protein for a newly identified neuropeptide nociceptin. Biochem. Biophys Res Commun 217 (1995) 539-545
193. Saito Y., Maruyama K., Kawano H., Hagino-Yamagishi K., Kawamura K., Saido T.C., and Kawashima S. Molecular cloning and characterization of a novel from of neuropeptide gene as a developmentally regulated molecule. J Biol Chem 271 (1996) 15615-15622
194. Saito Y., Maruyama K., Saido T.C., and Kawashima S. Over expression of a neuropeptide nociceptin/orphanin FQ precursor gene, N23K/N27K, induces neurite outgrowth in mouse NS20Y cells. J Neurosci Res 48 (1997) 397-406
195. Sakurada T., Sakurada S., Katsuyama S., Hayashi T., Sakurada C., Tan-No K., Johansson H., Sandin J., and Terenius L. Evidence that N-terminal fragments of nociceptin modulate nociceptin-induced scratching, biting and licking in mice. Neurosci Lett 279 (2000) 61-64
196. Sandin J., Georgieva J., Schott P.A., Ogren S.O., and Terenius L. Nociceptin/orphanin microinjected into hippocampus impairs spatial learning in rats. Eur J Neurosci 9 (1997) 194-197
197. Saper C.B. The central autonomic system. In: Paxinos G. (Ed). The Rat Nervous System (1995), Academic Press, Sydney 107-135
198. Schuligoi R., Amann R., Angelberger P., and Peskar B.A. Determination of nociceptin-like immunoreactivity in the rat dorsal spinal cord. Neurosci Lett 224 (1997) 136-138
199. Schulz S., Schreff M., Nuss D., Gramsch C., and Hollt V. Nociceptin/orphanin FQ and opioid peptides show overlapping distribution but not co-localization in pain-modulatory brain regions. NeuroReport 7 (1996) 3021-3025
200. Schwerdtfeger W.K., Buhl E.H., and Germroth P. Disynaptic olfactory input to the hippocampus mediated by stellate cells in entorhinal cortex. J Comp Neurol 292 (1990) 163-177
201. Shimohigashi Y., Hatano R., Fujita T., Nakashima R., Nose T., Sujaku T., Saigo A., Shinjo A., and Nagahisa A. Sensitivity of opioid receptor-like receptor ORL1 for chemical modification on nociceptin, a naturally occurring nociceptive peptide. J Biol Chem 271 (1996) 23642-23645
202. Shu Y.S., Zhao Z.Q., Li M.Y., and Zhou G.M. Orphanin FQ/nociceptin modulates glutamate- and kainic acid-induced currents in acutely isolated rat spinal dorsal horn neurons. Neuropeptides 32 (1998) 567-571
203. 35S]Guanylyl-5′-O-(γ-thio)-triphosphate binding in guinea pig brain. J Comp Neurol 386 (1997) 562-572
204. 35S]GTP gamma S binding in rat brain. NeuroReport 7 (1996) 729-733
205. Simerly R.B. Anatomical substrates of hypothalamic integration. In: Paxinos G. (Ed). The Rat Nervous System (1995), Academic Press, Sydney 353-376
206. Simerly R.B., McCall L.D., and Watson S.J. Distribution of opioid peptides in the preoptic region: immunohistochemical evidence for a steroid-sensitive enkephalin sexual dimorphism. J Comp Neurol 276 (1988) 442-459
207. Sinchak K., Hendricks D.G., Baroudi R., and Micevych P. Orphanin FQ/nociceptin in the ventromedial nucleus facilitates lordosis in female rats. NeuroReport 8 (1997) 3857-3860
208. Slugg R.M., Ronnekleiv O.K., Grandy D.K., and Kelly M.J. Activation of an inwardly rectifying K+conductance by orphanin-FQ/nociceptin in vasopressin-containing neurons. Neuroendocrinology 69 (1999) 385-396
209. Standifer K.M., Cheng J., Brooks A.I., Honrado C.P., Su W., Visconti L.M., Biedler J.L., and Pasternak G.W. Biochemical and pharmacological characterization of mu, delta and kappa 3 opioid receptors expressed in BE(2)-C neuroblastoma cells. J Pharmacol Exp Ther 270 (1994) 1246-1255
210. Stanfa L.C., Chapman V., Kerr N., and Dickenson A.H. Inhibitory action of nociceptin on spinal dorsal horn neurons of the rat, in vivo. Br J Pharmacol 118 (1996) 1875-1877
211. Stratford T.R., Holahan M.R., and Kelly A.E. Injections of nociceptin into nucleus accumbens shell or ventromedial hypothalamic nucleus increase food intake. NeuroReport 8 (1997) 423-426
212. Sulaiman M.R., Niklasson M., Tham R., and Dutia M.B. Modulation of vestibular function by nociceptin/orphanin FQ: an in vivo and in vitro study. Brain Res 828 (1999) 74-82
213. Sun R.O., Zhao C.S., Wang H.J., Yang K., Chang J.K., and Han J.S. Nocistatin, a peptide reversing acute and chronic morphine tolerance. NeuroReport 12 (2001) 1789-1792
214. Takahashi T., Mizuta Y., and Owyang C. Orphanin FQ but not dynorphin A, accelerates colonic transit in rats. Gastroenterology 119 (2000) 71-79
215. Tian J.H., Xu W., Fang Y., Mogil J.S., Grisel J.E., Grandy D.K., and Han J.S. Bi-directional modulatory effect of orphanin FQ on morphine-induced analgesia: antagonism in brain and potentiation in spinal cord of the rat. Br J Pharmacol 120 (1997) 676-680
216. Tian J.H., Xu W., Zhang W., Fang Y., Grisel J.E., Mogil J.S., Grandy D.K., and Han J.S. Involvement of endogenous orphanin FQ in electroacupuncture-induced analgesia. NeuroReport 8 (1997) 497-500
217. Vanderah T.W., Raffa R.B., Lashbrook J., Burritt A., Hruby V., and Porreca F. Orphanin-FQ/nociceptin: lack of antinociceptive, hyperalgesic or allodynic effects in acute thermal or mechanical tests following intracerebroventricular or intrathecal administration to mice or rats. Eur J Pain 2 (1998) 267-280
218. Vaughan C.W., and Christie M.J. Increase by the ORL1 receptor (opioid receptor-like1) ligand, nociceptin, of inwardly rectifying K conductance in dorsal raphe nucleus neurons. Br J Pharmacol 117 (1996) 1609-1611
219. Vaughan C.W., Ingram S.L., and Christie M.J. Actions of the ORL1 receptor ligand nociceptin on membrane properties of rat periaqueductal gray neurons in vitro. J Neurosci 17 (1997) 996-1003
220. Vaughan C.W., Connor M., Jennings E.A., Marinelli S., Allen R.G., and Christie M.J. Actions of nociceptin/orphanin FQ and other prepronociceptin products on rat rostral ventromedial medulla neurons in vitro. J Physiol 534 (2001) 849-859
221. Wagner E.J., Ronnekleiv O.K., Grandy D.K., and Kelly M.J. The peptide orphanin FQ inhibits beta-endorphin neurons and neurosecretory cells in the hypothalamic arcuate nucleus by activating an inwardly-rectifying K+ conductance. Neuroendocrinology 67 (1998) 73-82
222. Walker J.R., Terenius L., and Koob G.F. Conditioned opioid withdrawal decreases nociceptin/orphanin FQ levels in the frontal cortex and olfactory tubercle. Neuropsychopharmacol 27 (2002) 203-211
223. Wang J.B., Johnson P.S., Imai Y., Persico A.M., Ozenberger B.A., Eppler C.M., and Uhl G.R. cDNA cloning of an orphan opiate receptor gene family member and its splice variant. FEBS Lett 348 (1994) 75-79
224. Wang X.M., Zhang K.M., and Mokha S.S. Nociceptin (orphanin FQ), an endogenous ligand for the QRL1 (opioid-receptor-like1) receptor; modulates responses of trigeminal neurons evoked by excitatory amino acids and somatosensory stimuli. J Neurophysiol 76 (1996) 3568-3572
225. Wang Y.Q., Zhu C.B., Wu G.C., Cao X.D., Wang Y., and Cui D.F. Effects of orphanin FQ on endomorphin-1 induced analgesia. Brain Res 835 (1999) 241-246
226. Watson R.E., Hoffmann G.E., and Wiegand S.J. Sexually dimorphic opioid distribution in the preoptic area: manipulation by gonadal steroids. Brain Res 398 (1986) 157-163
227. Wei W.Z., and Xie C.W. Orphanin FQ suppresses NMDA receptor-dependent long-term depression and depotentiation in hippocampal gyrus. Learn Mem 6 (1999) 467-477
228. Wick M.J., Minnerath S.R., Liana X., Elde R., Law P.Y., and Loh H.H. Isolation of a novel cDNA encoding a putative membrane receptor with high homology to the cloned mu, delta, and kappa receptors opioid. Brain Res Mol Brain Res 27 (1994) 37-44
229. Wu Y., Pu L., Ling K., Zhao J., Cheng Z., Ma L., and Pei G. Molecular characterization and functional expression of opioid receptor-like 1 receptor. Cell Res 7 (1997) 69-77
230. Xu X.J., Hao J.X., and Wiesenfeld-Hallin Z. Nociceptin or antinociceptin: potent spinal antinociceptive effect of orphanin FQ/nociceptin in the rat. NeuroReport 7 (1996) 2092-2094
231. Xu I.S., Hashemi M., Calo G., Regoli D., Wiesenfeld-Hallin Z., and Xu X.J. Effects of intrathecal nocistatin on the flexor reflex and its interaction with orphanin FQ nociceptin. NeuroReport 10 (1999) 3681-3684
232. Yakimova K.S., and Pierau F.K. Nociceptin/orphanin FQ: effects on thermoregulation in rats. Methods Find Exp Clin Pharmacol 21 (1999) 345-352
233. Yamamoto T., Nozaki-Taguchi N., and Kimura S. Analgesic effect of intrathecally administered nociceptin (orphanin FQ), an opioid receptor-like 1 receptor agonist, in the rat formalin test. Neuroscience 81 (1997) 249-254
234. Yamamoto T., Nozaki-Taguchi N., Sakashita Y., and Kimura S. Nociceptin/orphanin FQ: role in nociceptive information processing. Prog Neurobiol 57 (1999) 527-535
235. Yu T.P., and Xie C.W. Orphanin FQ/nociceptin inhibits synaptic transmission and long-term potentiation in rat dentate gyrus through postsynaptic mechanisms. J Neurophysiol 80 (1998) 1277-1284
236. Yu T.P., Fein J., Phan T., Evans C.J., and Xie C.W. Orphanin FQ inhibits synaptic transmission and long-term potentiation in rat hippocampus. Hippocampus 7 (1997) 88-94
237. Yu L.C., Lu J.T., Huang Y.H., Meuser T., Pietruck C., Gabriel A., Grond S., and Pierce-Palmer P. Involvement of endogenous opioid systems in nociceptin-induced spinal antinociception in rats. Brain Res 945 (2002) 88-96
238. Zamboni L., and DeMartino C. Buffered picric acid formaldehyde, a rapid new fixative for electron microscopy. J Cell Biol 35 (1967) 148A
239. Zaveri N., Polgar W.E., Olsen C.M., Kelson A.B., Grundt P., Lewis J.W., and Toll L. Characterization of opiates, neuroleptics, and synthetic analogs at ORL1 and opioid receptors. Eur J Pharmacol 428 (2001) 29-36
240. Zeilhofer H.U., Selbach U.M., Guhring H., Erb K., and Ahmadi S. Selective suppression of inhibitory synaptic transmission by nocistatin in the rat spinal cord dorsal horn. J Neurosci 20 (2000) 4922-4929
241. Zhao C.S., Li B.S., Zhao G.Y., Liu H.X., Luo F., Wang Y., Tian J.H., Chang J.K., and Han J.S. Nocistatin reverses the effect of orphanin FQ/nociceptin in antagonizing morphine analgesia. NeuroReport 10 (1999) 297-299
242. Zheng F., Grandy D.K., and Johnson S.W. Actions of orphanin FQ/nociceptin on rat ventral tegmental area neurons in vitro. Br J Pharmacol 136 (2002) 1065-1071
243. Zhu C.B., Cao X.D., Xu S.F., and Wu G.C. Orphanin FQ potentiates formalin-induced pain behavior and antagonizes morphine analgesia in rats. Neurosci Lett 235 (1997) 37-40